2021
DOI: 10.1007/s11916-021-00970-3
|View full text |Cite
|
Sign up to set email alerts
|

Models for Treating Post-traumatic Headache

Abstract: Purpose of Review To discuss the treatment of post-traumatic headache (PTH) and how to choose pharmacotherapy based upon known pathophysiology. Recent Findings Preclinical models of traumatic brain injury are finally revealing some of the mechanisms of PTH, including the significant role that inflammatory neuropeptides like calcitonin gene-related peptide (CGRP) play in the initiation and persistence of symptoms. Summ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 61 publications
0
16
0
Order By: Relevance
“…Studies should also include other potential treatments already available and used for other headache types. 114 Additionally, evaluation of when treatments are most effective and the optimum time for starting treatment is also needed. It is possible that early, aggressive treatment of those most at risk of prolonged headaches following an injury may lead to better outcomes.…”
Section: Future Directionsmentioning
confidence: 99%
See 3 more Smart Citations
“…Studies should also include other potential treatments already available and used for other headache types. 114 Additionally, evaluation of when treatments are most effective and the optimum time for starting treatment is also needed. It is possible that early, aggressive treatment of those most at risk of prolonged headaches following an injury may lead to better outcomes.…”
Section: Future Directionsmentioning
confidence: 99%
“…It is possible that early, aggressive treatment of those most at risk of prolonged headaches following an injury may lead to better outcomes. 114…”
Section: Future Directionsmentioning
confidence: 99%
See 2 more Smart Citations
“…Unfortunately, there is an extremely limited number of relevant clinical trials upon which to make therapeutic decisions for PTH management. The hope is that with greater clarity in PTH diagnostic criteria, with renewed interest in PTH ( 9 , 10 ) and with promising new emerging therapies, appropriate patients can be enrolled in clinical trials and novel therapeutic agents and treatment strategies can be appropriately evaluated.…”
Section: Introductionmentioning
confidence: 99%